An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform®
2020-07-04
عنوان الدراسة
An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform®
داعم الدراسة
Mundipharma
دواء الدراسة
Flutiform
رقم بروتوكول الدراسة
FLT18-KSA
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。